A Survey On The Management On The Management Of Maternal Hyperthyroidism During Lactation In Chongqing,China

Objective:We sought to investigate the current opinions on the management of maternal hyperthyroidism during lactation in Chongqing,China.Methods:700 doctors in Chongqing were invited to participate in an online survey to collect their opinions on the management of hyperthyroidism during lactation from April 1^stt to May 31^th,2018.Subgroup analysis was carried out according to the specialties,hospitals and professional ranks.Results:A total of 601 valid questionnaires were received.About half of the respondents did not recommend breastfeeding in uncontrolled maternal hyperthyroidism with or without anti-thyroid drug therapy.The answer“uncertain”was the most common among non-endocrinologists and junior doctors.79.1%of respondents used anti-thyroid drugs as the first-line therapy?methimazole by 35.8%and propylthiouracil by 43.3%?.56 out 601 respondents still chose“radioactive iodine”to treat hyperthyroidism during lactation,most of them were non-endocrinologists?n=49?.75%of respondents suggested taking anti-thyroid drugs after breastfeeding.Low iodine diet was the first frequent recommendation of respondents?47.3%?.96.8%of respondents suggested that endocrinologists should take part in hyperthyroidism health education during lactation.Conclusion:The standardized management of maternal hyperthyroidism during lactation still needs to be developed.